| cpd01112 | 1001202-20-5 | | GGGGXQACK | (3α,5β,7α,12α)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid | Synthesis | amide | Bode, Catherine A.et.al (2007)
DOI |
cpd01113 | 1001202-18-1 | tetrapeptide | GGGG | (3α,5β,7α,12α)-7-(acetyloxy)-12-[[(1,1-dimethylethoxy)carbonyl]amino]-3-[[(2-propen-1-yloxy)carbonyl]amino]-cholan-24-oic acid | Synthesis | amide | Bode, Catherine A.et.al (2007)
DOI | cpd01114 | 1000183-94-7 | | SATSSSGSGS | L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(3→13)-lactone | Antibiotic, antibacterial | amide | Nolan, Elizabeth M.et.al (2007)
DOI | cpd01115 | 1000183-93-6 | | SATSSSGSGS | L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(3→13)-lactone | Antibiotic, antibacterial | amide | Nolan, Elizabeth M.et.al (2007)
DOI | cpd01116 | 1000183-91-4 | | NSATSSSGSGS | L-Serine-N-(2,3-dihydroxybenzoyl)-O-[N-(2,3-dihydroxybenzoyl)-O-[N-(5-β-D-glucopyranosyl-2,3-dihydroxybenzoyl)-L-seryl]-L-seryl]-(3→13)-lactone | Antibiotic, antibacterial | amide | Nolan, Elizabeth M.et.al (2007)
DOI | cpd01117 | 960500-32-7 | | KXCKXC | Paclitaxel derivative | Antitumor therapy, cervical and prostate human cancer | sulfide | Papas, Serafim;et.al (2007)
DOI | cpd01118 | 960500-31-6 | | ECRGDS | Paclitaxel derivative | Antitumor therapy, cervical and prostate human cancer | sulfide | Papas, Serafim;et.al (2007)
DOI | cpd01119 | 960500-30-5 | | CRGDR | Paclitaxel derivative | Antitumor therapy, cervical and prostate human cancer | sulfide | Papas, Serafim;et.al (2007)
DOI | cpd01120 | 1059478-92-0 | | XRRRRRRRR | Phenytoin | Wound repair | amide | Kennedy, C.et.al (2007)
DOI | cpd01121 | 957047-47-1 | | YIYGSFK | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01122 | 957047-39-1 | | AIYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01123 | 957047-36-8 | | AEEEIYGEFEAKKKK | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01124 | 957047-33-5 | | IYGEFKKK | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01125 | 957047-31-3 | | EIYGEFKK | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01126 | 957047-28-8 | | EEIYGEFF | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01127 | 957047-25-5 | | YIYGSFK | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01128 | 957047-23-3 | | CIYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01129 | 957047-20-0 | | CIYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01130 | 957047-15-3 | | CYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01131 | 957047-13-1 | | IYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01132 | 957047-11-9 | | CIYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01133 | 957047-09-5 | | CIYKYY | 4-amino-α-methyl-1H-pyrazolo[3,4-d]pyrimidine-1-acetic acid | Antitiumor therapy, kinase inhibition | amide | Kumar, Anil;et.al (2007)
DOI | cpd01134 | 1032292-77-5 | tetrapeptide | XSNG | tert-Butyldiphenylsilyl chloride | Synthesis | silicone | Marchand, Arnaud;et.al (2007)
DOI | cpd01135 | 1032292-74-2 | tripeptide | XSX | tert-Butyldiphenylsilyl chloride | Synthesis | silicone | Marchand, Arnaud;et.al (2007)
DOI | cpd01136 | 1032292-71-9 | tetrapeptide | XSNG | tert-Butyldiphenylsilyl chloride | Synthesis | silicone | Marchand, Arnaud;et.al (2007)
DOI | cpd01137 | 1032292-69-5 | tetrapeptide | XSNG | 3′-O-Acetylthymidine | Synthesis | amide | Marchand, Arnaud;et.al (2007)
DOI | cpd01138 | 1032292-65-1 | tetrapeptide | XSNG | tert-Butyldiphenylsilyl chloride | Synthesis | silicone | Marchand, Arnaud;et.al (2007)
DOI | cpd01139 | 1032292-60-6 | tripeptide | XNG | 2,2,8-Trimethyl-4H-1,3-dioxino[4,5-c]pyridine-5-methanol | Synthesis | amide | Marchand, Arnaud;et.al (2007)
DOI | cpd01140 | 1032292-54-8 | tripeptide | XSX | 3′-O-Acetylthymidine | Synthesis | amide | Marchand, Arnaud;et.al (2007)
DOI | cpd01141 | 946144-06-5 | tetrapeptide | RGDS | Estradiol-3-carboxymethyl ether | Osteoporosis therapy, estrogen replacement | amide | Xiong, Yu;et.al (2007)
DOI | 
